Algert Global LLC Ironwood Pharmaceuticals Inc Transaction History

Algert Global LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.58 - $8.61 $79,236 - $122,261	14,200 New	14,200 $93,000
Q2 2022 Aug 15, 2022	SELL	$11.05 - $12.72 $400,706 - $461,265	-36,263 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$10.61 - $12.88 $384,750 - $467,067	36,263 New	36,263 $456,000
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $141,440 - $181,684	-13,024 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $155,246 - $181,294	13,024 New	13,024 $170,000
Q4 2019 Feb 18, 2020	SELL	$8.22 - $14.0 $317,892 - $541,422	-38,673 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.59 - $10.96 $332,201 - $423,856	38,673 New	38,673 $332,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.